DELCATH SYSTEMS, INC. Logo

DELCATH SYSTEMS, INC.

Interventional oncology company treating liver cancers with targeted chemotherapy.

DCTH | US

Overview

Corporate Details

ISIN(s):
US24661P8077
LEI:
Country:
United States of America
Address:
566 QUEENSBURY AVENUE, 12804 QUEENSBURY

Description

Delcath Systems, Inc. is a commercial-stage interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company develops and commercializes proprietary products for percutaneous hepatic perfusion (PHP), a minimally-invasive procedure designed to administer high-dose chemotherapy directly to the liver while controlling systemic exposure. Its flagship product in the United States is the HEPZATO KIT™ (melphalan/hepatic delivery system), an FDA-approved drug/device combination product for treating adult patients with metastatic uveal melanoma. In Europe, the company markets the CHEMOSAT® Hepatic Delivery System, a medical device for the same procedure.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-25 22:15 English 6.7 KB
2025-11-20 22:45
8-K
English 48.7 KB
2025-11-13 17:53 English 6.6 KB
2025-11-04 15:04
10-Q
English 1.3 MB
2025-11-04 14:02
8-K
English 93.6 KB
2025-10-20 12:01
8-K
English 146.5 KB
2025-10-18 00:05 English 12.4 KB
2025-08-15 22:46
S-8
English 64.8 KB
2025-08-15 22:15
8-K
English 132.4 KB
2025-08-06 15:14
10-Q
English 1.5 MB
2025-08-06 14:03
8-K
English 92.9 KB
2025-06-13 23:22 English 7.5 KB
2025-05-22 13:15
8-K
English 66.7 KB
2025-05-19 22:10 English 7.4 KB
2025-05-19 22:10 English 7.4 KB

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Binex Co., Ltd. Logo
Biopharmaceutical firm with pharma manufacturing and biologics CDMO services.
South Korea
053030
BioAge Labs, Inc. Logo
A clinical-stage biotech developing therapies for metabolic diseases by targeting aging.
United States of America
BIOA
BioAtla, Inc. Logo
Develops antibody-based therapeutics activated within the tumor microenvironment.
United States of America
BCAB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures medical aesthetic products like H.A. fillers and skincare.
South Korea
489460
BioCardia, Inc. Logo
Develops cell-derived therapeutics for cardiovascular and pulmonary diseases.
United States of America
BCDA
Biocartis Group NV Logo
Develops and commercializes an automated molecular diagnostics platform for oncology.
Belgium
BCART
Bioceltix S.A. Logo
Develops stem cell-based medicinal products for veterinary use.
Poland
BCX
BIOCRYST PHARMACEUTICALS INC Logo
Develops novel medicines for patients with rare and serious diseases.
United States of America
BCRX
Biodexa Pharmaceuticals Plc Logo
Clinical-stage biopharma developing treatments for rare diseases, diabetes, and cancer.
United States of America
BDRX
Biofarm S.A. Logo
A pharmaceutical company that manufactures and markets medicines and dietary supplements.
Romania
BIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.